 TEL AVIV, Israel , May 18, 2022 PRNewswire -- Chemomab Therapeutics Ltd. Nasdaq: CMMB, Chemomab, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, today announced that management will participate in the virtual portion of the H.C. 